Home › Core › ISCC-IDs › 28C2d1wJs5E3M

View ISCC-ID

Core Data

28C2d1wJs5E3M
ISCC-ID - digital asset identifier
CCBqCvx781DDZ-CTrq33ALtXCDJ-CD8TQf3nukbeg-CRienZmLRE2pZ
ISCC-CODE - digital asset descriptor
2QTa5N4aeSrCB2MLoPdPF4AsTjstJgcLTnd
PUBLIC-KEY or WALLET-ADDRESS of DECLARING PARTY
0
Number of times updated

Seed Metadata (Immutable)

study of availability according to direction and dosage regimen of delapril

Ledger Reference

coblo
Source Ledger/Blockchain
6028
N-th ISCC Decleration on source ledger
5b0699a9771d90aab2fb935d69b07ce9395d044a969625a098dc6b285df15dd6
Hash of block that includes the ISCC-DECLARATION
bf68299d20a0e9706b01880c66739c2472a6e2b40eb270b99f68de48f7d09be1
Hash of transaction that includes the ISCC-DECLERATION
0
Output index that includes ISCC-DECLERATION (UTXO based chains)

Mutable Metadata

[{"data": {"name": "Study of availability according to direction and dosage regimen of delapril.", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "TAKEHIKO MIKAWA", "@type": "Person"}], "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://www.jstage.jst.go.jp/article/jscpt1970/23/1/23_1_245/_pdf", "encodingFormat": "application/pdf"}], "publisher": {"name": "Japanese Society of Clinical Pharmacology and Therapeutics", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.3999/jscpt.23.245", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CCBqCvx781DDZ-CTrq33ALtXCDJ-CD8TQf3nukbeg-CRienZmLRE2pZ", "propertyID": "ISCC"}], "datePublished": "1992-01-01"}, "schema": "schema.org", "mediatype": "application/ld+json"}]
Close